

%201.webp)


%201.webp)




LSPedia Global Serialization Series
序列化并非一刀切。美国、欧盟、亚洲和中东的法规要求各不相同,企业必须应对错综复杂的要求。您准备好实现全球合规了吗?
.avif)
欢迎来到 LSPedia,在这里,创新与奉献相遇。
如果您热衷于有所作为,并能在协作环境中茁壮成长,LSPedia 就是您的理想之选。



%201.webp)


%201.webp)




序列化并非一刀切。美国、欧盟、亚洲和中东的法规要求各不相同,企业必须应对错综复杂的要求。您准备好实现全球合规了吗?
.avif)
如果您热衷于有所作为,并能在协作环境中茁壮成长,LSPedia 就是您的理想之选。

Serial numbers were built for compliance. What they reveal about your supply chain is worth far more.
Counterfeit and diverted pharmaceuticals aren't hypothetical risks, they're active threats with real legal, financial, and patient safety consequences. In this installment of LSPedia's Value Beyond Compliance series, we go beyond the mandate to examine what robust serialization and traceability programs actually do when product integrity is on the line. Join us for an expert conversation on how the data you're already collecting can become your strongest line of defense and what happens when it isn't.
𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗣𝗮𝗻𝗲𝗹𝗶𝘀𝘁: 𝗔𝗯𝗵𝗮 𝗞𝘂𝗻𝗱𝗶, 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗔𝘁𝘁𝗼𝗿𝗻𝗲𝘆 | 𝗔𝗿𝗲𝗻𝗙𝗼𝘅 𝗦𝗰𝗵𝗶𝗳𝗳
Abha brings deep expertise in pharmaceutical enforcement and regulatory law, offering a firsthand perspective on how counterfeit and diversion cases develop — and what they mean for manufacturers, distributors, and dispensers caught in the crosshairs. Compliance gets you in the game. Security keeps patients safe.
𝗪𝗵𝗮𝘁 𝘄𝗲’𝗹𝗹 𝗰𝗼𝘃𝗲𝗿:
✅ How serialization data exposes counterfeit and diverted product in the supply chain
✅ Real enforcement actions: what regulators are finding and how investigations unfold
✅ The legal and financial consequences trading partners face when product integrity fails
✅ Practical steps to move from compliance posture to genuine supply chain security
.webp)